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Abstract
Particulate matter (PM) is a major component of urban air pollution and has a significant effect on human health. 
Natural PM sources are volcanic eruptions, dust storms, forest and grassland fires, living vegetation and sea spray. 
Traffic, domestic heating, power plants and various industrial processes generate significant amounts of anthropogenic 
PM. PM consists of a complex mixture of solid and liquid particles of organic and inorganic substances suspended 
in the air. The chemical composition of particles is very complex and depends on emission sources, meteorological 
conditions and their aerodynamic diameter. Several epidemiological studies have demonstrated that exposure to 
PM of varying size fractions is associated with an increased risk of respiratory and cardiovascular diseases. Adverse 
health effects have been documented from studies of both acute and chronic exposure. The most severe effects in 
terms of overall health burden include a significant reduction in life expectancy by a several months for the average 
population, which is linked to long-term exposure to moderate concentrations of PM. Nevertheless, numerous deaths 
and serious cardiovascular and respiratory problems have also been attributed to short-term exposure to peak levels 
of PM. Although many studies attribute greater toxicity to smaller size fractions, which are able to penetrate deeper 
into the lung, the molecular mechanisms and the size fractions of the PM that are responsible for the observed 
diseases are not completely understood.
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Izvleček 
Prašni delci so eden najpogostejših onesnaževal zraka in imajo velik vpliv na zdravje ljudi. Kemijska sestava prašnih 
delcev je zelo zapletena in je odvisna od vira emisij, meteoroloških okoliščin in od aerodinamskega premera delcev. 
Naravni izvori prašnih delcev so vulkanski izbruhi, puščavski pesek, naravni požari in morska sol. Promet, domača 
kurišča, termoelektrarne in industrijski obrati pa so glavni vir antropogenih prašnih delcev. Prašni delci so sestavljeni 
iz zapletene mešanice trdnih in tekočih delcev, sestavljenih iz organskih in anorganskih snovi. Številne epidemiološke 
študije so pokazale, da je izpostavljenost prašnim delcem različnih velikosti povezana s povečanim tveganjem za 
razvoj dihalnih in srčno-žilnih obolenj. Škodljiv učinek na zdravje je bil ugotovljen na osnovi raziskav, ki so proučevale 
akutno, in na osnovi raziskav, ki so proučevale kronično izpostavljenost prašnim delcem. Najbolj škodljiv učinek 
prašnih delcev je skrajšanje življenjske dobe povprečne populacije za nekaj mesecev, kar je povezano z dolgoročno 
izpostavljenostjo prašnim delcem zmernih koncentracij. Kljub temu pa so vzroki za številne smrti in resne dihalne 
ter srčno-žilne bolezni povezane s kratkoročno izpostavljenostjo visokim koncentracijam prašnih delcev. Številne 
raziskave pripisujejo večje negativne učinke na zdravje ljudi manjšim prašnim delcem, ker lahko globlje prodrejo v 
pljuča. Kljub številnim raziskavam še ni popolnoma pojasnjeno, kateri prašni delci so ključni za povzročene neželene 
učinke in prek katerih molekularnih mehanizmov sprožajo neželene učinke.
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and also in chronic obstructive pulmonary diseases 
(COPD) has been observed in developed countries 
over the last 3 decades (11, 12, 13, 14, 15, 16). The 
adverse effect of PM on respiratory health has a 
quantifiable impact, not only on the morbidity but also 
on the mortality of respiratory diseases (17, 18). 
On the other hand the possible association between 
cardiovascular diseases (CVD) and exposure to 
airborne PM has only recently been addressed. As 
reviewed in several papers (19, 20, 21), exposure to 
PM as a result of outdoor air pollution has become a 
recognized risk factor for adverse cardiovascular events 
including cardiovascular mortality, cardiac arrhythmia, 
myocardial infarction (MI), myocardial ischemia, and 
heart failure (22, 23, 24, 25).
Additionally, the mortality in cities with high levels of air 
pollution exceeds that observed in relatively cleaner 
cities by 15–20 %. Even in the EU, the average life 
expectancy is 8.6 months lower due to exposure to PM 
produced by human activities (5, 26). 
In the present review, the components of air pollution 
are presented and the effect of PM exposure on the 
cardiovascular and respiratory system is analysed.
2 THE COMPONENTS OF AIR  
 POLLUTION
PM is a major component of urban air pollution and 
has a major effect on human health, nature and 
atmosphere. PM10 means PM that passes through a 
size-selective inlet with a 50 % efficiency cut-off at 10 
µm aerodynamic diameter (27). Likewise PM2.5 means 
particles that pass through a size-selective inlet with a 
50 % efficiency cut-off at 2.5 μm aerodynamic diameter. 
The limit value for the annual average concentration for 
PM10 is 40 µg/m3. The limit value for 24 h averages, 
which may be exceeded 35 times per year, is 50 μg/m3 
for PM10. For air quality monitoring purposes, PM10 
measurements are most widely used at present. EU 
Member states were also obliged to gather information 
on the concentrations of fine PM2.5 particles. The 
target value of 25 µg/m3 for PM2.5 entered into force 
on 01/01/2010 and the limit value enters into force on 
01/01/2015 (28). The World Health Organization (WHO) 
recommended limits for the concentration of PM10 is 
20 µg/m3 and 10 µg/m3 for PM2.5 (29).
2.1 Natural and anthropogenic sources
Sources of PM can be classified as natural or 
anthropogenic. Natural sources include volcanic 
eruptions, dust storms, forest and grassland fires, 
1 INTRODUCTION
Air pollutants are a heterogeneous mixture of gaseous 
and particulate matter (PM). The main gaseous 
components of air pollution include NO2, SO2, CO, O3, 
NH3, carbonyl compounds, and organic solvents (1, 
2, 3, 4). On the other hand, PM is made of solid and 
liquid particles from traffic, industry, domestic heating 
and various natural sources.
Air pollution, both indoors and outdoors, is a major 
environmental health problem affecting the majority of 
the population on Earth. It is estimated that air pollution 
causes 3.1 million premature deaths worldwide every 
year (5). Adverse health effects have been documented 
after short-term exposure to peak levels of PM, as well 
as after long-term exposure to moderate concentrations. 
Long-term exposure to moderate levels of fine PM has 
been estimated to reduce life expectancy by as much as 
several months (5). Nevertheless, numerous deaths and 
serious cardiovascular and respiratory problems have 
been attributed to short-term exposure to peak levels. 
The scientific literature on PM epidemiology suggests 
an association between ambient PM exposures and 
various acute health outcomes, including hospital 
admissions, inflammatory responses in the respiratory 
tract, the exacerbation of asthma and decreased lung 
functions (6, 7). 
A number of groups within the population have potentially 
increased vulnerability to the effects of exposure to 
PM. Groups that develop increased sensitivity include 
the elderly (8), those with pre-existing heart and lung 
disease (6) or diabetes (9), children (10), those who 
are exposed to other toxic materials that interact with 
PM and those who are socioeconomically deprived 
(8). Another group within the population includes 
those members who are simply exposed to unusually 
large amounts of PM. The literature of the findings 
indicates that sensitive populations are susceptible to 
more severe symptoms, including coughs, phlegm, 
wheezing, shortness of breath, bronchitis, increased 
asthma attacks and the aggravation of lung or heart 
disease (6, 9, 10).
In developing countries, exposure to pollutants from 
the indoor combustion of solid fuels on open fires or 
traditional stoves increases the risk of acute lower 
respiratory infections and associated mortality among 
young children; indoor air pollution is also a major risk 
factor for chronic obstructive pulmonary disease and 
lung cancer among adults (5). On the other hand in 
developed countries, the human respiratory tract has 
to deal with a much wider variety of ambient particles 
and gasses. An increase in the prevalence of respiratory 
diseases, such as rhinosinusitis and bronchial asthma 
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living vegetation and sea spray. For some natural 
primary emissions, a strong annual cycle is typical 
(30, 31). Human activities, such as traffic, domestic 
heating, power plants and various industrial processes 
also generate significant amounts of anthropogenic 
aerosols. Regulators in both the United States of 
America and Europe have required significant emission 
reductions from land-based emission sources, while 
air pollution from ships went largely unregulated until 
recently (32, 33). The diesel used by ships is usually 
very dirty fuel that cannot be used for land-based 
transport. Projections show that by the year 2020, the 
SO2 emissions from international shipping are expected 
to equal or even exceed land-based sources (34).
2.2 Primary and secondary aerosols
Airborne suspended PMs can be also classified as 
primary or secondary. Primary particles are emitted 
directly into the atmosphere formed by friction, fossil fuel 
burning and wind erosion, whereas secondary particles 
are formed in the atmosphere by the transformation of 
different gaseous precursors, e.g. SO2, NOX, NH3 (35, 
36, 37, 38, 39, 40), see Figure 1. Gaseous precursors 
are transformed in to secondary PMs in complex photo-
chemical reactions in the air. The common components 
of atmospheric particles, such as sulphate, nitrate, 
ammonium, organic compounds, crustal material and 
water, reach a particulate phase through several photo-
chemical processes (41). A major fraction of the ambient 
PM arises from atmospheric gas-to-particle conversion.
2.3 The size and chemical composition of 
Particulate Matters
PM consists of a complex mixture of solid, liquid or solid 
and liquid particles of organic and inorganic substances 
suspended in the air. Besides the varying emission 
sources, PM also differs in chemical composition and 
size. Size properties govern the transport and removal 
of particles from the air; they also govern their deposition 
within the respiratory system and are associated with 
the chemical composition and sources of particles. In 
this way, particles are usually sampled and described on 
the basis of their aerodynamic diameter. Three separate 
size groups of particulate matter are distinguished: 
 – PM10: diameter <10 µm (coarse fraction)
 – PM2.5: diameter <2.5 μm (fine fraction)
 – Diameter <0.1 μm (ultra-fine fraction)  
Figure 1. The major components of particulate matters.
 Particles such as ash, dust, sea salt, water 
(H2O), organic carbon (OC) and elemental 
carbon (EC) are directly emitted into the 
atmosphere. The common components 
of atmospheric particles are sulphate 
(SO2), nitrate (NOx) and primary gaseous 
organics. These components reach the 
particulate phase through several gas-phase-
photochemical (GPP) processes.
Slika 1. Sestava prašnih delcev.
 Prašni delci, kot so pepel, prah, morska 
sol, voda (H2O), organski ogljik (OO) in 
elementarni ogljik (EO) so v ozračje emitirani 
neposredno.  Zelo pogosti prašni delci v zraku 
so delci sulfatov (SO2), nitratov (NOx) in 
hlapnih organskih spojin, ki nastanejo preko 
številnih fotokemičnih (FKP) procesov. 
Particles with different aerodynamic diameters come 
from different emission sources. Coarse particles are 
mainly formed by mechanical processes, while fine 
and ultrafine particlesare directly emitted (e.g. biomass 
burning, diesel soot) and formed by chemical reactions 
from gaseous precursors. Fine and ultra-fine particles 
contain secondarily formed aerosols (gas-to-particle 
conversion), combustion particles and recondensed 
organic and metal vapours. Coarse particles usually 
contain dust from roads, industry and earth crust 
materials. The fine fraction contains most of the acidity 
and mutagenic activity of PM (42). The largest number 
of particles can be found in the fine and ultra-fine 
fractions – i.e. with an aerodynamic diameter less than 
2.5 µm (43, 44). 
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The chemical composition of particles is very complex 
and depends on the emission sources, meteorological 
conditions and their aerodynamic diameter. Airborne 
PM constituents are a mixture of organic and inorganic 
substances (45, 46, 47, 48, 49, 50). Studies show 
that the major components of PM include: geological 
material (metal oxides), organic carbon, elemental 
carbon, sulphate (SO2), nitrate (NOX) and ammonium 
(NH3). PM10 sources vary by geographic latitude and 
longitude. Traffic in urban places and industrial activities 
are the most important PM10 sources. The variation 
of PM10 concentrations is controlled by the rate of 
emission in PM10 sources and by the meteorological 
conditions. Calm conditions with a low mixing height 
in a cold season usually lead to higher concentrations 
than during the summer period. As reported by various 
research studies (51, 52, 53, 54, 55, 56), the main 
meteorological factors are wind (speed and direction), 
temperature, monsoon, rain effect and dust storms. 
3 PARTICULATE MATTER AND  
 HEALTH EFFECTS
Exposure to PM has been linked to a number of different 
health outcomes, including lung inflammatory reactions, 
reduction in lung function, adverse effects on the 
cardiovascular system, visit to the hospital emergency 
department, admission to hospital, and death. Adverse 
health effects have been documented by studies of both 
acute and chronic exposure. The most severe effects 
in terms of overall health burden include a significant 
reduction in life expectancy of the average population by 
a several months, which is linked to long-term exposure 
to moderate concentrations of PM (57). Nevertheless, 
numerous deaths and serious cardiovascular and 
respiratory problems have also been attributed to 
short-term exposure to peak levels of PM. In particular, 
pulmonary function studies are suggestive of short-term 
effects resulting from ambient PM exposures. Such 
outcomes include hospital admissions, inflammatory 
responses in the respiratory tract, the exacerbation of 
asthma and decreased lung functions (58). 
3.1 Particulate matter exposure and respiratory 
morbidity
The association between increased levels of air 
pollution and the mortality and morbidity rates from 
respiratory diseases is well-established (22, 59). 
Positive associations have been observed between 
urban air pollution (especially road traffic) and 
respiratory symptoms in children (60, 61, 62, 63, 64, 
65). Gauderman et al. have demonstrated that PM 
can negatively influence lung development in children 
and adolescents. They have shown that exposure 
to ambient air pollution is correlated with significant 
deficits in respiratory growth over an eight-year 
period, leading to clinically important deficits in lung 
function at the age of 18 (66, 67). PM has also been 
significantly associated with emergency department 
visits due to asthma, wheezing, bronchitis and lower 
respiratory tract symptoms, as well as with the use of 
anti-asthma medication and physician visits concerning 
asthma (13, 17, 68, 69). Respiratory morbidity and 
mortality have also been related to admissions for 
pneumonia, pulmonary emboli and COPD (70). Strong 
epidemiological evidence additionally suggests that 
exposure to PM causes an exacerbation of pre-existing 
lung conditions, such as COPD, resulting in increased 
morbidity and mortality (16).
There is also some evidence to indicate that high levels 
of PM are correlated with the rising trend in allergic 
respiratory diseases and bronchial asthma. Laboratory 
studies have confirmed epidemiologic evidence that air 
pollution may facilitate the access of inhaled allergens 
to the cells of the immune system, thus promoting the 
sensitization of the airway (13). 
3.2 Particulate matter exposure and 
cardiovascular morbidity
The increase in risk of adverse clinical cardiovascular 
outcomes associated with particulate air pollution is 
relatively small compared to the traditional risk factors 
such as smoking, as well as diet, obesity, diabetes 
and metabolic syndrome. But particulate air pollution 
exposes a much larger number of individuals in the 
population and over an entire lifetime. Thus the relatively 
small cardiovascular effects of PM translate into a 
serious and major public health impact.
A review of the findings (71) has shown that several 
epidemiological studies have demonstrated that 
exposure to ambient air pollutants is a major cause 
of increase in hospital admissions for cardiovascular 
diseases. Some studies have confirmed that an 
increase in PM10 or PM2.5 results in an increased 
risk of hospitalization for myocardial infarction (MI), 
dysrhythmias, heart failure and cardiac arrest (72, 
73, 74, 75, 76, 77, 78). With regard to non-fatal 
outcomes, the risk of MI has been estimated to be 
1.48 times greater for a small increase in particulate 
air pollution (25 µg/m3 in the preceding two hours) (23). 
In comparison, the risk of MI was recently reported to 
be nearly 3-times higher in current smokers compared 
to non-smokers (79). Studies have described an 
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association between the increase of air pollutants and 
the development of atherosclerosis. The increase of 
PM2.5 has been described in humans as coinciding with 
the incidence of atherosclerosis processes and carotid 
intima-media thickness (80, 81). Additional research 
has suggested that there is a link between exposure to 
PM and heart rate variability (82). Studies show that a 
temporary increase in PM concentrations may lead to 
an increased risk of ischemic stroke, cardiac ischemia 
and coronary artery disease, as well as variations in 
systolic and diastolic blood pressure values (20, 76, 
83, 84). It has been proposed that PM inhalation can 
increase deep vein thrombosis and coagulation (85, 
86, 87). Additionally, it has been demonstrated that PM 
exposure can induce changes in numerous proteins 
associated with coagulation, which increases C-reactive 
protein (88), plasminogen activator inhibitor-1 (89), 
fibrinogen (90), and the von Willebrand factor (88). 
Brook et al. proposed in 2004 that PM components 
might induce endothelial dysfunction, platelet activation 
and alterations in coagulation. These events may 
elicit plaque rupture and thrombosis by increasing 
atherosclerotic plaque instability, conditions that will 
lead to either MI or stoke (19).
3.3 Association between particulate matter and 
mortality
Since most of the world’s population is potentially 
exposed to PM in its entire possible fraction, WHO 
has estimated that 3.1 million deaths are caused 
each year by PM (5). Most of the currently available 
epidemiological studies on the health effects of PM 
use mortality as the indicator of health, because of the 
relatively easy access to information on population 
mortality. Some studies have shown a significant 
association between daily mortality from respiratory 
and cardiovascular diseases and PM (18, 24, 91). 
The Health Effects Institute re-analysis has shown an 
increase in cardiovascular mortality with an increase 
in fine PM (92). Medina et al. estimated in 2004 that a 
reduction in PM10 concentrations by only 5 µg/m3 would 
prevent approximately 3300 to 7700 deaths per year 
(93). Aphekom’s projects have shown that a decrease 
to 10 µg/m3 of long-term exposure to PM2.5 could add 
up to 22 months of life expectancy for persons 30 years 
of age and older (94). Pope et al. reported in 2004 
that a 10 μg/m3 elevation of PM2.5 is associated with 
an increased risk of mortality ranging from 8 % to 18 
% (95). The results from the APHENA study reported 
that a 10 μg/m3 elevation of PM10 is associated with 
an increased risk of mortality from all causes across all 
ages ranging from 0.2 % to 0.6 % (7). Approximately 
one million individuals are at risk of death from CVD 
related to particulate air pollution exposures worldwide 
each year (96).
3.4 Possible mechanisms of particulate matters 
that leads to cardio- respiratory diseases
The effect of PM on lung function depends on the type 
of pollutant and its environmental concentration, the 
duration of exposure, the total ventilation of the exposed 
individuals and the interaction between air pollution and 
aeroallergens such as pollens and fungal spores (13).
The main mechanisms of deposition of PM in the 
lungs are impaction, sedimentation and diffusion (97). 
Impaction is thought to be the principal mechanism 
of large PM deposition. Sedimentation happens to 
particles that are allowed to fall under their own force 
of gravity. And diffusion affects the smallest particles 
as they are displaced by random gas motion and will 
principally occur in the small airways and gas exchange 
regions of the lung. 
The respiratory tract is lined with a thin liquid layer (ELF), 
composed of various agents such as antioxidants, lipids 
and proteins (98). The main component of the ELF is 
surfactants, which reduce surface tension and displace 
PM less than 6 μm in diameter (99). Also proteins in the 
surfactant help macrophages target and clear PM (98). 
So, lung phagocytes are the first line of defence in the 
cellular response of the lungs to inhaled PM (100). While 
human lung parenchyma retains PM2.5, particles larger 
than 6 μm only reach the proximal airways, where they 
are eliminated by mucociliary clearance if the airway 
mucosa is intact. The alveolar macrophages (AM) and 
bronchial and alveolar epithelial cells are the principle 
cells that process inhaled airborne particles in the lung. 
They produce pro-inflammatory mediators that have 
the ability to elicit both a local inflammatory response 
in the lung tissues and also a systemic inflammatory 
response (101, 102).
The exposure of AMs to PM influences their phagocyte 
activity, increases their oxidant production and releases 
pro-inflammatory mediators such as tumour necrosis 
factor-α and interleukin-1β that are important in 
mediating the local and systemic inflammatory response 
(102). Lung epithelial cells, which have a large surface 
area, are also important in processing inhaled particles 
due to the production of several pro-inflammatory 
mediators (103, 104, 105). In summary AMs and lung 
epithelial cells determine the profile and the magnitude 
of the mediator response in the lung following exposure 
to PM.
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The major conduit for the translocation of PM into 
body is the respiratory tract (Figure 2). The majority 
of the coarse PM fraction are deposited in the nasal, 
pharyngeal and laryngeal regions (106). On the other 
hand, particles in the size fraction PM2.5-0.1 are 
deposited in the alveolar ducts and sacs (106) and 
have been shown to be especially toxic (25, 107, 108) 
(Figure 2). 
Figure 2.  PM deposition in the respiratory system. 
 The major conduit for the translocation of 
PM into body is the respiratory tract. The 
majority of the coarse PM (PM10) fractions 
are deposited in the nasal, pharyngeal and 
laryngeal regions, PM5 are deposited in the 
tracheas, while fine and ultrafine particles 
(PM2.5-0.1), due to their small size, are 
deposited deep into the lungs, in the alveolar 
ducts and sacs.
Slika 2.  Odlaganje prašnih delcev v dihalnem sistemu. 
 Prašni delci v telo vstopajo preko dihalnega 
sistema. Večji delci (PM10) se v dihalnem 
sistemu ustavijo v nosni sluznici, v grlu in 
v žrelu. Nekoliko manjši prašni delci (PM5) 
se lahko odložijo v sapniku, frakcije manjših 
prašnih delcev (PM2.5-0.1) pa lahko zaradi 
izjemno majhne velikosti pridejo in se odložijo 
v pljučne mešičke. 
While the precise biological mechanisms linking PM 
exposure to CVD is yet unclear, likely mechanisms 
include systemic inflammation subsequent to pulmonary 
inflammation, alterations of the autonomic nervous 
system that lead to changes in heart rate and heart 
ratevariability, and the translocation of particles 
(specifically UFP) or soluble components (e.g., 
transition metals) from the lungs directly into systemic 
circulation (21).
Several studies have shown that UFPs are able to move 
across the blood barrier of the lung and enter into the 
bloodstream (109, 110). Two studies showed that the 
UFPs can spread beyond the lungs and cause damage 
to other organs, such as the brain (111, 112). However, 
several studies have shown that the translocation 
to systemic circulation is negligible (113, 114, 115). 
Regarding the effect of PM on the autonomic nervous 
system, it has been suggested that PM deposited in the 
pulmonary tree can stimulate sensory nerve reflexes 
that alter the systemic autonomic balance (21). 
4 CONCLUSIONS
Several epidemiological and experimental studies have 
identified that air pollution with PM, and especially its 
fine fraction, affects the health of most of the population, 
leading to a wide range of acute and chronic health 
problems and to a reduction in life expectancy.  Although 
many studies attribute greater toxicity to the smaller 
size fractions, evidence that these particles make up 
part of the internal constituents of PM10 has to be 
taken into consideration. Health effects associated 
with PM exposure are generally known, though the 
molecular mechanisms and size fractions of the PM 
that are responsible for the observed diseases are less 
known. It has also been proposed that the number of 
ultra-fine particulates is more relevant than the mass of 
PM (116). There is no clear, direct evidence identifying 
which of the many sources of PM are responsible for the 
effects and, in particular, to what extent these effects 
are caused by PM from the long-range transport of 
pollution. Also there remain some uncertainties as to 
the precise contribution of pollution from regional versus 
local sources in causing the effects observed in both 
short- and long-term epidemiological studies. It would 
also be necessary to distinguish between the long 
and short-term effects of PM on health and to clarify 
the molecular mechanisms underlying the effects of 
PM on the cardiovascular system. It is necessary to 
determine the nature of the components of PM in all 
the size fractions and to investigate the incidence and 
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effects of PM10 on health, alongside PM2.5,, PM1 
and nanoparticles. In research work published in the 
Journal of Molecular Cell Biology (117) data provides 
a molecular explanation for nanoparticle-induced lung 
injury and raised concern about the safety of some 
nanomaterials.  
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